Habitual use of acetaminophen as a risk factor for chronic renal failure: A comparison with phenacetin

American Journal of Kidney Diseases

Volumn 28, Issue 1 SUPPL., 1996, Pages

  Buckalew V M , Jr ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

acetaminophen; Analgesic associated nephropathy; phenacetin

Indexed keywords

PARACETAMOL; PHENACETIN;

ARTICLE; CHRONIC KIDNEY FAILURE; DRUG EFFECT; DRUG USE; HUMAN; RISK ASSESSMENT; RISK FACTOR;

EID: 0030017604     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0272-6386(96)90562-4     Document Type: Article

References (31)

1. O Spühler HU Zollinger Die chronisch-interstitielle nephritis Ztsch Klin Med 151 1953 1 50
2. VM Buckalew Jr HM Schey Renal disease from habitual antipyretic analgesic consumption: An assessment of the epidemiologic evidence Medicine 11 1986 291 303
3. RM Murray DH Lawson AL Linton Analgesic nephropathy. Clinical syndrome and prognosis BMJ 1 1971 479 482
4. P Kincaid-Smith Pathogenesis of the renal lesion associated with the abuse of analgesics Lancet 1 1967 859 862
5. A Burry J Hopkins Phenacetin and analgesic nephropathy Med J Aust 1 1972 879 882
6. N Hultengren C Lagergren A Ljungqvist Carcinoma of the renal pelvis in renal papillary necrosis Acta Chir Scand 130 1965 314 320
7. U Bengtsson S Johansson L Angervall Malignancies of the urinary tract and their relation to analgesic abuse Kidney Int 13 1978 107 113
8. U Bengtsson B Hood Abuse of phenacetin-containing analgesics and renal damage EH Kass Progress in Pyelonephritis 1965 Davis Philadelphia, PA 297 306
9. A Kasanen The effect of the restriction of the sale of phenacetin on the incidence of papillary necrosis established at autopsy Ann Clin Res 5 1973 369 374
10. US Food and Drug Administration Human drugs: Prescription and over-the-counter drug products containing phenacetin; withdrawal of approval of new drug application Fed Reg 48 1983 15466 15469
11. JL Vanherweghem D Even-Adin Epidemiology of analgesic nephropathy in Belgium Clin Nephrol 17 1982 129 133
12. W Pommer G Glaeske M Molzahn The analgesic problem in the Federal Republic of Germany: Analgesic consumption, frequency of analgesic nephropathy and regional differences Clin Nephrol 26 1986 273 278
13. FP Brunner NH Selwood EDTA-ERA Registry Committee End-stage renal failure due to analgesic nephropathy, its changing pattern and cardiovascular mortality Nephrol Dial Transplant 9 1994 1371 1376
14. GE Schubert BA Bethke Capillarosclerosis of the renal pelvis: Autopsy study for estimating the incidence of phenacetin and paracetamol abuse Eur Urol 12 1986 327 330
15. M Morlans J-R Laporte X Vidal D Cabeza PD Stolley End-stage renal disease and non-narcotic analgesics: A case control study Br J Clin Pharmacol 30 1990 717 723
16. APS Disney Australia and New Zealand Dialysis and Transplant Registry Demography and survival of patients receiving treatment for chronic renal failure in Australia and New Zealand: Report on dialysis and renal transplantation treatment from the Australia and New Zealand Dialysis and Transplant Registry ed 7 Am J Kidney Dis 25 1995 165 175
17. LM Noels MM Elseviers ME de Broe Impact of legislative measures on the sales of analgesics and the subsequent prevalence of analgesic nephropathy: A comparative study in France, Sweden and Belgium Nephrol Dial Transplant 10 1995 167 174
18. JH Stewart M McCredie APS Disney TH Mathew Trends in incidence of end-stage renal failure in Australia, 1972–1991 Nephrol Dial Transplant 9 1994 1377 1382
19. UC Dubach B Rosner E Pfister Epidemiologic study of abuse of analgesics containing phenacetin N Engl J Med 308 1983 357 362
20. TG Murray PD Stolley JC Anthony R Schinnar E Hepler-Smith JL Jeffreys Epidemiologic study of regular analgesic use and end-stage renal disease Arch Intern Med 143 1983 1687 1693
21. DP Sandler JC Smith CR Weinberg VM Buckalew Jr VW Dennis WB Blythe WP Burgess Analgesic use and chronic renal disease N Engl J Med 320 1989 1238 1243
22. TV Perneger PK Whelton MJ Klag Risk of kidney failure associated with the use of acetaminophen, aspirin, and nonsteroidal antiinflammatory drugs N Engl J Med 331 1994 1675 1679
23. W Pommer E Bronder E Greiser U Helmert HJ Jesdinsky A Klimpel K Borner M Molzahn Regular analgesic intake and the risk of end-stage renal failure Am J Nephrol 9 1989 403 412
24. NK Steenland MJ Thun CW Ferguson FK Port Occupational and other exposures associated with male endstage renal disease: A case/control study Am J Public Health 80 1980 153 159
25. BJ Barrett Acetaminophen and adverse chronic renal outcomes An appraisal of the epidemiologic evidence ed 7 Am J Kidney Dis 28 1996 S14 S19 (suppl 1)
26. LW Bluemle Jr M Goldberg Renal accumulation of salicylate and phenacetin: Possible mechanisms in the nephropathy of analgesic abuse J Clin Invest 47 1968 2507 2514
27. M Segasothy AB Suleiman M Puvaneswary A Rohana Paracetamol: A cause for analgesic nephropathy and endstage renal disease Nephron 50 1988 50 54
28. AC Hauser K Derfler P Balcke Progression of renal insufficiency in analgesic nephropathy: Impact of continuous drug abuse J Clin Epidemiol 44 1991 53 56
29. PJ Tuso D Nortman Renal magnesium wasting associated with acetaminophen abuse Conn Med 56 1992 421 423
30. JM Burkart VM Buckalew Jr Nephropathy associated with habitual ingestion of acetaminophen Kidney Int 31 1987 192
31. A Schwartz Analgesic associated nephropathy Klin Wochenschr 65 1987 1 16